Vancouver - Ondine Biopharma Corp. has filed a preliminary short form prospectus in certain provinces of Canada to qualify, on a commercially reasonable efforts basis, the offering through Canaccord Capital Corp. and Sprott securities Inc. of common shares of the company. The offering may also occur by private placement in the US, the UK and other jurisdictions in Europe. Proceeds from this offering will be used to finance the ongoing development of the company's PhotoDynamic Disinfection technology and general working capital.
No comments:
Post a Comment